Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exosome component 5 (EXOSC5) is a structural, non-catalytic subunit of the multi-protein RNA exosome complex, a highly conserved ribonucleoprotein machinery essential for the processing, maturation, and decay of a broad spectrum of nuclear and cytoplasmic RNAs. EXOSC5 does not possess intrinsic ribonuclease activity but forms part of the central ring that scaffolds and regulates access to catalytic subunits, impacting gene expression quality control, defense response to viral RNA, and cell cycle regulation. Dysregulation of EXOSC5 expression is implicated in carcinogenesis, particularly in solid and hematologic cancers, through its modulation of cell proliferation via AKT and STAT3 signaling pathways. Genetic variants affecting EXOSC5 function cause complex syndromic diseases marked by neurological, cardiac, and developmental abnormalities, highlighting both its clinical relevance and safety challenges in therapeutic targeting.
Indirect: Suppress EXOSC5-driven cancer cell proliferation by inhibiting downstream signaling (AKT and STAT3). Pathway targeting: Disruption of AKT and STAT3 phosphorylation to block cell cycle progression.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosome component 5 (EXOSC5).